Abstract
Purpose:
Previous studies have reported alterations in total retinal blood flow (TRBF), oxygen delivery (DO2), oxygen metabolism (MO2), and oxygen extraction fraction (OEF) due to retinal diseases. The purposes of the current study were to determine variabilities and establish normal confidence intervals (CIs) for these metrics.
Methods:
A total of 22 healthy and 14 diabetic subjects participated in the study. Retinal vascular oxygen saturation (SO2) and TRBF were measured by oximetry and Doppler optical coherence tomography, respectively. DO2, MO2, and OEF were calculated from SO2 and TRBF measurements. Means, standard deviations (SDs), and CIs of metrics were determined in healthy subjects. Intra-visit variability was determined by the mean SDs of repeated measurements. Inter-visit variability was determined by the difference of measurements between two visits.
Results:
TRBF was 44 ± 15 µL/min (95% CI, 37–51) in healthy subjects. Intra-visit variabilities of TRBF were 5 µL/min and 6 µL/min in healthy and diabetic subjects, respectively. Inter-visit variability of TRBF was 3 µL/min in diabetic subjects. DO2, MO2, and OEF were 8.3 ± 2.9 µLO2/min (95% CI, 7.0–9.6), 3.2 ± 0.9 µLO2/min (95% CI, 2.8–3.6), and 0.40 ± 0.08 (95% CI, 0.36–0.43), respectively, in healthy subjects. Inter-visit variabilities of DO2, MO2, and OEF were 0.6 µLO2/min, 0.1 µLO2/min, and 0.03, respectively, in diabetic subjects.
Conclusions:
The findings established variabilities and normal baselines for TRBF, DO2, MO2, and OEF measurements in a small cohort of subjects.
Translational Relevance:
The variability and normal baselines of retinal oxygen metrics may be useful for diagnosing and monitoring patients with retinal diseases.
Determining the variabilities of TRBF and oxygen metrics (DO2, MO2, and OEF) is necessary to determine alterations due to certain diseases and monitor changes over time. In the current study, intra-visit variability of TRBF and inter-visit variability of TRBF, DO2, MO2, and OEF were reported. Additionally, normal 95% CIs for these metrics were established in healthy subjects.
Previous studies have reported intra-visit coefficient of variation of TRBF to be 4% in diabetic subjects
24 and 8% to 11% in healthy subjects.
22,31 These values are slightly lower than 10% in healthy subjects and 12% in diabetic subjects in the current study. Multiple factors can contribute to differences in measurement variabilities, such as subjects’ fixation and eye motion, the numbers of subjects evaluated and measurements obtained per subject, as well as previously demonstrated differences in technical instrumentation,
32 and age of subjects.
33 On the other hand, inter-visit variability of TRBF in the current study (3 µL/min) was lower than previously reported variabilities of 6 µL/min and 11 µL/min in young and elderly healthy subjects, respectively.
22
TRBF measurements in the current study were in agreement with previously reported values obtained using Doppler OCT methods.
24,27,31,34,35 Additionally, the current study showed no significant difference in TRBF between healthy and diabetic subjects with no DR or untreated mild NPDR. Consistent with our results, other studies also reported no significant decrease in TRBF at the early stages of DR.
24,36 However, one study reported lower TRBF in mild-to-moderate NPDR subjects compared to control subjects.
4
Finally, our finding of an inverse correlation between TRBF and age in healthy subjects agrees with published reports of decreases in retinal vessel density, venular blood flow velocity, and artery blood column diameter associated with aging.
33,37–39 The reduction in TRBF with age can be attributed to both vascular constriction and reduced vessel density, as previously suggested.
33
DO
2, MO
2, and OEF measurements in healthy subjects in the current study were comparable to those reported in previous studies.
1,3,5,29 Additionally, normal 95% CIs established in healthy subjects provide a baseline for evaluating changes due to diseases. The current study also reported inter-visit variability of these metrics in diabetic subjects with no DR or mild NPDR. These results may be potentially used in future longitudinal studies to determine progressive changes in oxygen metrics over time or evaluate treatment outcomes.
The current study had limitations. First, inter-visit variability of retinal oxygen metrics was assessed in diabetic subjects. Although the diabetic subjects had no or minimal retinopathy with oxygen metrics within the normal CIs at both visits and the time interval between visits was relatively short, the potential for changes over time may not be eliminated. Second, the sample size for this study was small, which may have limited the accurate establishment of normal baselines. Additionally, due to the small sample size, the potential effects of age, race, and sex on the variability of measurements were not evaluated, and differences in race could not be accounted for. Future studies with larger cohorts and multiple visits are necessary to determine more accurately the variabilities and normal CIs of metrics according to race, sex, and age.
Overall, the findings established variabilities and normal baselines for TRBF, DO2, MO2, and OEF measurements, providing a basis for detecting and monitoring changes due to retinal diseases.
Supported by grants from the National Eye Institute, National Institutes of Health (EY030115 and EY029220) and by an unrestricted departmental award from Research to Prevent Blindness.
MS designed the study. MR and SL performed image analysis. MR and MS analyzed the data. MR wrote and edited the manuscript. MR, SL, NPB, and MS read and revised the manuscript. MS approved the manuscript for submission.
Presented in part at the Association for Research in Vision and Ophthalmology virtual meeting, May 1–7, 2021.
Disclosure: M. Rahimi, None; S. Leahy, None; N.P. Blair, None; M. Shahidi, None